Brief: Silo Pharma Awarded US Patent For PTSD Treatment, Prepares For SPC-15 Clinical Trial
08/01/2025 14:17
Jan 8 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA AWARDED US PATENT FOR GROUNDBREAKING PTSD
TREATMENT
AND PREPARES FOR SPC-15 CLINICAL TRIAL
Source text: urn:newsml:reuters.com:*:nGNX4q9XhL
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement